End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 CNY | -0.04% | +10.27% | +2.06% |
Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 2 M€ | -12.95% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - | |
1.18% | 96 M€ | -2.05% | ||
0.51% | 35 M€ | -5.85% | - | |
0.27% | 4 M€ | -11.56% | ||
0.15% | 11 M€ | +3.37% | ||
0.07% | 1 M€ | +3.49% | - | |
0.07% | 3 M€ | -.--% | - | |
0.03% | 2,808 M€ | +7.67% | - | |
0.03% | 441 M€ | +6.14% | - | |
0.03% | 149 M€ | +3.96% | - | |
0.03% | 117 M€ | +1.00% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.01% | 31 M€ | +4.25% | - | |
0.00% | 7 M€ | +2.57% | - | |
0.00% | 34 M€ | +2.04% | - | |
0.00% | 389 M€ | +6.96% | - | |
0.00% | 34 M€ | +6.21% | - | |
0.00% | 39 M€ | +3.82% | - | |
0.00% | 302 M€ | +4.53% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.06% | 40.55B | |
+29.68% | 681B | |
+19.14% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+13.53% | 235B | |
+4.42% | 199B | |
-12.35% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.